Oramed Granted Key European Patent for Platform Technology in Oral Delivery of Proteins
– Protease inhibitor is a key component of Oramed’s PODTM technology that protects therapeutic proteins in the digestive system – Oramed has already been granted this patent in the United States and Japan NEW YORK , Jan. 5, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc.
